Satya
India - HyderabadBiotechnology
Focus: Satya is a small-molecule focused biotechnology company headquartered in Hyderabad, India, with oncology as its primary therapeutic area. Limited public data suggests an early-to-mid stage biotech operation.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Satya
AI assessmentNot HiringNo open roles listed right now. Follow Satya to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Triamcinolone Acetonide
Shoulder CapsulitisClinical Trials (1)
NCT01570985Treatment Study of Frozen Shoulder: Corticosteroid Injection in Joint Versus Wait and See Policy
Phase 3Help build intelligence for Satya
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.